MUFG Americas’s GALENA BIOPHARMA INC COM RXII Stock Holding History

MUFG Americas’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-309	Closed	–	–	1702
2013 Q2	$0	Buy	+309	New	–	﹤0.01%	1625

Other funds holding RXII

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

MUFG Americas's RXII Position: Q3 2013 in Review

MUFG Americas sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2013, closing a stake of 309 shares.

MUFG Americas first reported a position in RXII in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 73 funds tracked by Wall St. Rank hold RXII as of Q3 2013.

MUFG Americas reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2013 after selling out during the quarter.
MUFG Americas sold 309 GALENA BIOPHARMA INC COM shares in Q3 2013.
MUFG Americas first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 1 quarter.
MUFG Americas's GALENA BIOPHARMA INC COM position peaked at $0 in Q2 2013.
73 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2013.

Based on MUFG Americas's 13F filing for Q3 2013, filed 8 Nov 2013.